Align Technology, Inc. (ALGN)
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Align Technology Shares Hurt by Macro Issues, Decline in ASPs
ALGN is facing a decline in Invisalign ASPs for comprehensive treatment options. This resulted in a decline in the company's revenues.
2 Strong Stocks to Buy Now While They're Still on Sale
Two stocks (ALGN and KO) to buy in January trading at least 20% below their average Zacks price targets that also offer great long-term value.
Align Technology Boosted By Improving Sentiment, Easing Comps, Margins, Earns Analyst Upgrade
Leerink Partners upgraded Align Technology Inc ALGN, citing upside opportunities throughout 2025 given gross margin expansion opportunities.
Align Technology: Economic Headwinds Cloud An Attractive Growth Story
Align Technology shares have remained under pressure over the past year due to soft consumer demand for the company's clear aligner products. I expect growth to accelerate to at least 5% in FY25, mainly driven by strong demand for the systems and services that are sold to doctors. Profit margins are expected to improve, following the restructuring program initiated in Q4.
Should You Hold Align Technology Stock in Your Portfolio Right Now?
ALGN stock stays on investors' radar, courtesy of its strong Invisalign potential and success with iTero.
Align Shares Down on Macroeconomic Issues, ASP Challenges
ALGN is facing a decline in Invisalign ASPs for comprehensive treatment options. This results in a decline in the company's revenues.
Is the Options Market Predicting a Spike in Align Technology (ALGN) Stock?
Investors need to pay close attention to Align Technology (ALGN) stock based on the movements in the options market lately.
Why Is Align Technology (ALGN) Up 5.5% Since Last Earnings Report?
Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock?
ALGN Stock to Gain From CE Mark Win for Invisalign Palatal Expander
Align Technology achieves a CE mark for the Invisalign Palatal Expander System.
ALGN Stock Rise on the Release of Invisalign Smile Architect Software
Align Technology unveils Invisalign Smile Architect software with Multiple Treatment Plans for providing customised treatment.
Align Technology: A Change In Plans After Mixed Q3 Earnings
Align Technology reported mixed Q3 earnings, with a beat on EPS at $2.35 but a slight miss on revenue at $977.87M. Despite challenges in the U.S. market, growth in Asia Pacific, EMEA, and Latin America, and increased Clear Aligner volume, show resilience. Align's growth drivers include product enhancements, infrastructure investments, and partnerships, with expected revenue growth of 5.29%-7.53% year-over-year from Q4 2024 to Q4 2026.
